Changes in Beta-Cell Function during Dapagliflozin Therapy in Combination with Exenatide in Type 2 Diabetes Patients (T2D)

被引：0
|
作者：
Defronzo, Ralph A.
Baskoy, Gozde
Triplitt, Curtis L.
Cersosimo, Eugenio
Solis-Herrera, Carolina
Adams, John M., II
Hansis-Diarte, Andrea A.
Gastaldelli, Amalia
Chavez, Alberto
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-1550-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1550-P
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Dapagliflozin and measures of cardiovascular autonomic function in patients with type 2 diabetes (T2D)
    Ang, Lynn
    Kidwell, Kelley M.
    Dillon, Brendan
    Reiss, Jacob
    Fang, Fang
    Leone, Virginia
    Mizokami-Stout, Kara
    Pop-Busui, Rodica
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (08)
  • [2] Islet Autoimmunity Is Highly Prevalent and Associated with Diminished Beta-Cell Function in Patients with Type 2 Diabetes (T2D) in the GRADE Study
    Brooks-Worrell, Barbara
    Hampe, Christiane S.
    Gonzalez, Erica V.
    Palomino, Brenda M.
    Zangeneh, Sahar Z.
    Utzschneider, Kristina
    Kahn, Steven E.
    Larkin, Mary E.
    Johnson, Mary L.
    Mather, Kieren J.
    Younes, Naji
    Rasouli, Neda
    Desouza, Cyrus
    Cohen, Robert M.
    Park, Jean Y.
    Florez, Hermes
    Valencia, Willy Marcos
    Shojaie, Ali
    Palmer, Jerry P.
    Balasubramanyam, Ashok
    DIABETES, 2020, 69
  • [3] Dapagliflozin (DAPA) in Patients with Type 2 Diabetes (T2D) and Mixed Dyslipidemia
    Bays, Harold E.
    Sartipy, Peter
    Xu, John
    Langkilde, Anna Maria
    Sjostrom, C. David
    DIABETES, 2016, 65 : A306 - A306
  • [4] Dorzagliatin Improves Beta-Cell Function in Patients with Type 2 Diabetes
    Zhang, Yuanhui
    Feng, Lingge
    Chen, Li
    Liu, Dongyang
    DIABETES, 2023, 72
  • [5] PRESERVATION OF BETA-CELL FUNCTION IN TYPE 2 DIABETES
    Nyalakonda, Kavita
    Sharma, Tarang
    Ismail-Beigi, Faramarz
    ENDOCRINE PRACTICE, 2010, 16 (06) : 1038 - 1055
  • [6] Beta-cell function and mass in type 2 diabetes
    Larsen, Marianne O.
    DANISH MEDICAL BULLETIN, 2009, 56 (03) : 153 - 164
  • [7] Effect of Combination SGLT2i and GLP-1RA Therapy on Glycemic Control, Body Weight, and Beta-Cell Function in Type 2 Diabetic (T2D) Subjects
    Martinez, Robert A.
    Al-Gburi, Karrar
    Al Jobori, Hussein
    Adams, John
    Abdul-Ghani, Muhammad
    Triplitt, Curtis
    Defronzo, Ralph A.
    Cersosimo, Eugenio
    DIABETES, 2017, 66 : LB44 - LB44
  • [8] Beta-Cell Dedifferentiation in Patients with Type 2 Diabetes
    Chung, Cheng-Ho
    DIABETES, 2014, 63 : A540 - A540
  • [9] Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes
    Gastaldelli, Amalia
    Repetto, Enrico
    Guja, Cristian
    Hardy, Elise
    Han, Jenny
    Jabbour, Serge A.
    Ferrannini, Ele
    DIABETES OBESITY & METABOLISM, 2020, 22 (03): : 393 - 403
  • [10] Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes (T2D): Outcomes by Body Mass Index (BMI)
    Shatskov, Alla
    Rezvani, Geoffrey
    Mansfield, Traci
    DIABETES, 2016, 65 : A299 - A299
12345